Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition(s):Locally Advanced Head and Neck Squamous Cell CarcinomaLast Updated:May 6, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Locally Advanced Head and Neck Squamous Cell CarcinomaLast Updated:May 6, 2023Not yet recruiting
Condition(s):Advanced Cutaneous Squamous Cell CarcinomaLast Updated:March 28, 2023Terminated
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:August 24, 2023Not yet recruiting
Condition(s):HPV-Related Squamous Cell Carcinoma; Head and Neck Squamous Cell CarcinomaLast Updated:September 7, 2023Recruiting
Condition(s):Oral Squamous Cell CarcinomaLast Updated:September 11, 2020Unknown status
Condition(s):Advanced Cutaneous Squamous Cell CarcinomaLast Updated:February 2, 2024Active, not recruiting
Condition(s):Metastatic Skin Squamous Cell Carcinoma; Recurrent Skin Squamous Cell CarcinomaLast Updated:July 19, 2023Recruiting
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:October 26, 2022Not yet recruiting
Condition(s):Squamous Cell CarcinomaLast Updated:December 15, 2023Active, not recruiting
Condition(s):Esophageal Squamous Cell CarcinomaLast Updated:August 10, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.